Josef von Mering helped to discover barbiturates, a class of sedative drugs used for insomnia, epilepsy, anxiety, and anesthesia. In 1903, he published observations that barbital (then known as diethyl-barbituric acid) has sedative properties in humans.
Josef von Mering's work on barbiturates led to the development of a class of drugs used for insomnia, epilepsy, anxiety, and anesthesia. In 1903, he published findings that barbital (then known as diethyl-barbituric acid) had sedative effects in humans.